A webcast of the fireside chat can be accessed under the "Events" tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The ...
As part of our commitment to addressing health inequities, Blue Cross Blue Shield of Massachusetts ("Blue Cross") and MassChallenge today announced the five participants of the 2025 Health Equity ...
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and ...
Praxis management will also be participating in one-on-one investor meetings at the Jefferies Biotech on the Bay Summit, taking place at the Ritz Carlton South Beach Hotel in Miami on Tuesday, March ...
On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Leerink ...
In a report released today, Sung Ji Nam from Scotiabank maintained a Buy rating on Veracyte (VCYT – Research Report), with a price target of ...
DURAVYU™ has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback